The first state court trial in a lawsuit
alleging Xarelto causes internal bleeding kicked off today in Philadelphia,
following three federal cases in which Xarelto makers Janssen Pharmaceuticals
Inc and Bayer Pharma AG prevailed. The three previous trials were out of the federally
consolidated MDL in New Orleans, although one trial took place in Mississippi.
There are approximately 1,400 Xarelto
cases pending in the Philadelphia Court of Common Pleas. There are close to
18,000 cases pending in the MDL. A lot of pretrial motions in October dealt
with the exclusions of both sides’ experts, and a question of whether punitive
damages would be allowed to be sent to the jury. Hopefully the plaintiff
prevails in this case, although there are several other cases set in
Pennsylvania.
Pittman, Dutton & Hellums, P.C., is
currently investigating Xarelto cases. If you or a loved one were prescribed
Xarelto and suffered an irreversible internal bleeding that lead to
hospitalization and/or death, contact Booth Samuels at toll free 1-866-515-8880
or by email at booths@pittmanudutton.com
